piracetam has been researched along with Premenstrual Syndrome in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Premenstrual Syndrome: A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam is a novel antiepileptic drug which has shown strong anti-kindling activity in animal models of epilepsy." | 2.73 | Levetiracetam for treatment of premenstrual dysphoric disorder: a pilot, open-label study. ( Halbreich, U; Kayatekin, ZE; Sabo, AN, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kayatekin, ZE | 1 |
| Sabo, AN | 1 |
| Halbreich, U | 1 |
1 trial available for piracetam and Premenstrual Syndrome
| Article | Year |
|---|---|
Levetiracetam for treatment of premenstrual dysphoric disorder: a pilot, open-label study.
Topics: Adult; Anticonvulsants; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Foll | 2008 |